Notícias · Recifes

New AI system provides treatment recommendations for complex blood cancers

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed "HemaGuide," an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has

Admin Recifes 15/07/2026 2

New virus catalog reveals which pathogens pose the greatest threat

In a typical year, scientists discover two or three viruses that have never been seen in people before. The number fluctuates, but the trend has been fairly steady since the 1960s.

Admin Recifes 15/07/2026 2

The myth of the 'lizard brain' and the real trade-off inside your mind

So many of life's most pivotal decisions come down to one question: Should you listen to your logic or your emotions? Popular culture often frames this tension as a struggle between two minds—a "more evolved" rational layer built atop an ancient "lizard brain" driven by primal in

Admin Recifes 15/07/2026 2

Preparing for Andes virus outbreaks to prevent transmission in health care settings

Andes virus, the type of hantavirus responsible for the outbreak on the MV Hondius cruise ship earlier this year, has a fatality rate of up to 36%. Precautions such as isolation of infected individuals and use of personal protective equipment by health care personnel can prevent

Admin Recifes 15/07/2026 2

Mediterranean diet is associated with better psychological well-being, study suggests

Following a Mediterranean diet may provide additional benefits for mental health. A new study has now linked it to greater psychological well-being among people over 50. The research is the result of a collaboration between University College London and the Barcelona Institute fo

Admin Recifes 15/07/2026 2

Blood test may help identify which colorectal cancer patients most likely to benefit from

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

Admin Recifes 15/07/2026 2

Study reveals how the uterine microbiome may impact pregnancy success

Researchers from Trinity College Dublin have uncovered new evidence that the communities of bacteria living in the uterus may play an important role in determining whether pregnancy is successful following assisted reproductive technologies (ART) such as IVF. Among the key findin

Admin Recifes 15/07/2026 2

New brush test detects oral cancer in one hour

A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London researchers validates the use of a noninvasive brush biopsy test that can detect oral cancer within one hour.

Admin Recifes 15/07/2026 2

The 'healthier' drink that isn't: Popular alcoholic beverages found to be ultra-processed

Canned cocktails and hard seltzers are being chosen by health-conscious young people as a safer way to consume alcohol, but new Australian research reveals these products are almost universally ultra-processed, potentially giving consumers a false sense of security and underminin

Admin Recifes 15/07/2026 3

Fibronectin pathway may drive Marfan aortic damage, opening new drug targets

A new study published in Nature Communications identifies a molecular signaling pathway that contributes to the development of life-threatening aortic aneurysms and dissections in Marfan syndrome, a genetic disorder affecting connective tissue. The findings provide new insight in

Admin Recifes 15/07/2026 2

Natural regulator may slow several cancers by shutting down fibroblasts, study finds

An international research team co-led by the Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC-CSIC-University of Cantabria) and CIC bioGUNE, member of BRTA, has identified a novel molecular mechanism that helps limit the progression of several types of cancer.

Admin Recifes 15/07/2026 3

Longer persistence seen with Upadacitinib versus tumor necrosis factor inhibitors in rheum

Patients with rheumatoid arthritis (RA) have longer persistence with upadacitinib than tumor necrosis factor inhibitors (TNFi), according to a study published online June 23 in Rheumatology.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes